VACCINATION AGAINST HEPATITIS-A - COMPARISON OF DIFFERENT SHORT-TERM IMMUNIZATION SCHEDULES

被引:11
作者
JILG, W
BITTNER, R
BOCK, HL
CLEMENS, R
SCHATZL, H
SCHMIDT, M
ANDRE, FE
DEINHARDT, F
机构
[1] UNIV REGENSBURG, INST MED MICROBIOL & HYG, W-8400 REGENSBURG, GERMANY
[2] UNIV MUNICH, MAX VON PETTENKOFER INST HYG & MED MICROBIOL, W-8000 MUNICH 2, GERMANY
[3] SMITHKLINE BEECHAM BIOL, RIXENSART, BELGIUM
关键词
HEPATITIS-A VACCINATION; RAPID IMMUNIZATION; IMMUNIZATION SCHEDULES; EARLY IMMUNE RESPONSE;
D O I
10.1016/0264-410X(92)90565-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A total of 114 healthy young adults were immunized with hepatitis A vaccine using different vaccination schedules. Individuals received either a single dose (group 1), two doses given simultaneously (group 2), two doses at days 0 and 14 (group 3) or at days 0 and 28 (group 4), or three doses at days 0, 7 and 21 (group 5). Two weeks after a single dose, seroconversion rates between 77 and 85% were achieved (groups 1, 3, 4). All individuals immunized with two doses within two weeks (groups 2, 3, 5) had antibodies to hepatitis A vaccine (anti-HAV positive) by week 3; these participants also showed clearly higher mean anti-HA V values (geometric mean titres, GMTs) at this time than those individuals vaccinated only once. GMTs at week 8 were 560 IU/l in group 5, 236, 339 and 428 IU/l in groups 2-4 and 102 IU/l in group 1. Of participants with anti-HAV at week 8, 82 were again tested 4 months later; all were still seropositive. Ten individuals were tested during the first three weeks at 3-4 day intervals for anti-HA V immunoglobulin M (IgM); specific IgM responses were not detectable before day 10 but were present in eight of 10 vaccinees by day 14.
引用
收藏
页码:S126 / S128
页数:3
相关论文
共 6 条
[1]  
ANDRE FE, 1990, PROG MED VIROL, V37, P72
[2]  
FLEHMIG B, 1989, LANCET, V1, P1039
[3]   SAFETY AND IMMUNOGENICITY OF A LIVE ATTENUATED HEPATITIS-A VIRUS-VACCINE IN SERONEGATIVE VOLUNTEERS [J].
MIDTHUN, K ;
ELLERBECK, E ;
GERSHMAN, K ;
CALANDRA, G ;
KRAH, D ;
MCCAUGHTRY, M ;
NALIN, D ;
PROVOST, P .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (04) :735-739
[4]  
SJOGREN MH, 1991, VIRAL HEPATITIS AND LIVER DISEASE, P88
[5]   HEALTH-PROBLEMS AFTER TRAVEL TO DEVELOPING-COUNTRIES [J].
STEFFEN, R ;
RICKENBACH, M ;
WILHELM, U ;
HELMINGER, A ;
SCHAR, M .
JOURNAL OF INFECTIOUS DISEASES, 1987, 156 (01) :84-91
[6]   SAFETY AND IMMUNOGENICITY OF AN INACTIVATED HEPATITIS-A CANDIDATE VACCINE IN HEALTHY ADULT VOLUNTEERS [J].
WIEDERMANN, G ;
AMBROSCH, F ;
KOLLARITSCH, H ;
HOFMANN, H ;
KUNZ, C ;
DHONDT, E ;
DELEM, A ;
ANDRE, FE ;
SAFARY, A ;
STEPHENNE, J .
VACCINE, 1990, 8 (06) :581-584